OMX Nordic 40
2.512,59
PKT
-13,96
PKT
-0,55
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.06.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 26.06.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 26.06.25 | AstraZeneca Outperform | Bernstein Research | |
| 25.06.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 25.06.25 | Volvo (B) Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Volvo (B) Underperform | Bernstein Research | |
| 24.06.25 | Volvo (B) Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG | |
| 18.06.25 | Volvo (B) Underperform | Bernstein Research | |
| 17.06.25 | Novo Nordisk Buy | UBS AG | |
| 16.06.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.06.25 | Novo Nordisk Buy | UBS AG | |
| 13.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 12.06.25 | Volvo (B) Underperform | Bernstein Research | |
| 12.06.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.06.25 | Volvo (B) Underperform | Bernstein Research | |
| 10.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 10.06.25 | Volvo (B) Buy | Deutsche Bank AG | |
| 10.06.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 09.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.06.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 04.06.25 | Volvo (B) Buy | UBS AG | |
| 04.06.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 03.06.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |